FENNEC PHARMACEUTICALS INC.

Profile

Company Names

FENNEC PHARMACEUTICALS INC.
ADHEREX TECHNOLOGIES INC

Addresses

68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC 27709

Phone Numbers

(919) 636-4530
919-636-4530

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$11,400,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2017-06-08 
$7,600,000.00 
$7,600,000.00 
$0.00 
Equity 
2
2014-12-03 
$2,200,000.00 
$2,200,000.00 
$0.00 
Equity 
1
2013-11-22 
$1,600,000.00 
$1,600,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ADRIAN 
 
HAIGH 
DIRECTOR
FENNEC PHARMACEUTICALS INC.   |  ARCH BIOPARTNERS INC.
KHALID 
 
ISLAM 
DIRECTOR
FENNEC PHARMACEUTICALS INC.   |  GAIN THERAPEUTICS, INC.   |  PROCESSA PHARMACEUTICALS, INC.
KRYSIA 
 
LYNES 
EXECUTIVE OFFICER
ADHEREX TECHNOLOGIES INC   |  FENNEC PHARMACEUTICALS INC.
CHRIS 
 
RALLIS 
DIRECTOR
AEOLUS PHARMACEUTICALS, INC.   |  FENNEC PHARMACEUTICALS INC.
CHRIS 
A. 
RALLIS 
DIRECTOR
AEOLUS PHARMACEUTICALS, INC.   |  OXYGEN BIOTHERAPEUTICS, INC.   |  ADHEREX TECHNOLOGIES INC   |  TENAX THERAPEUTICS, INC.
ROSTISLAV 
 
RAYKOV 
EXECUTIVE OFFICER, DIRECTOR
FENNEC PHARMACEUTICALS INC.   |  AMARILLO GOLD CORP.   |  LAVRAS GOLD CORP.
ROTISLAV 
 
RAYKOV 
EXECUTIVE OFFICER, DIRECTOR
ADHEREX TECHNOLOGIES INC
STEVEN 
 
SKOLSKY 
DIRECTOR
ADHEREX TECHNOLOGIES INC   |  FENNEC PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-06-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-06-08 
2014-12-15
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-12-03 
2013-11-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-11-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#